1. Home
  2. MDXG vs PLSE Comparison

MDXG vs PLSE Comparison

Compare MDXG & PLSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • PLSE
  • Stock Information
  • Founded
  • MDXG 2006
  • PLSE 2014
  • Country
  • MDXG United States
  • PLSE United States
  • Employees
  • MDXG N/A
  • PLSE N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • PLSE Medical/Dental Instruments
  • Sector
  • MDXG Health Care
  • PLSE Health Care
  • Exchange
  • MDXG Nasdaq
  • PLSE Nasdaq
  • Market Cap
  • MDXG 1.3B
  • PLSE 1.2B
  • IPO Year
  • MDXG N/A
  • PLSE 2016
  • Fundamental
  • Price
  • MDXG $8.57
  • PLSE $23.57
  • Analyst Decision
  • MDXG Strong Buy
  • PLSE
  • Analyst Count
  • MDXG 5
  • PLSE 0
  • Target Price
  • MDXG $12.00
  • PLSE N/A
  • AVG Volume (30 Days)
  • MDXG 617.6K
  • PLSE 127.7K
  • Earning Date
  • MDXG 02-26-2025
  • PLSE 03-27-2025
  • Dividend Yield
  • MDXG N/A
  • PLSE N/A
  • EPS Growth
  • MDXG N/A
  • PLSE N/A
  • EPS
  • MDXG 0.52
  • PLSE N/A
  • Revenue
  • MDXG $342,804,000.00
  • PLSE N/A
  • Revenue This Year
  • MDXG $9.56
  • PLSE N/A
  • Revenue Next Year
  • MDXG $9.19
  • PLSE N/A
  • P/E Ratio
  • MDXG $16.49
  • PLSE N/A
  • Revenue Growth
  • MDXG 10.93
  • PLSE N/A
  • 52 Week Low
  • MDXG $5.47
  • PLSE $6.60
  • 52 Week High
  • MDXG $10.14
  • PLSE $23.62
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 41.31
  • PLSE 59.71
  • Support Level
  • MDXG $8.29
  • PLSE $17.35
  • Resistance Level
  • MDXG $9.30
  • PLSE $22.05
  • Average True Range (ATR)
  • MDXG 0.30
  • PLSE 1.22
  • MACD
  • MDXG -0.04
  • PLSE 0.26
  • Stochastic Oscillator
  • MDXG 27.10
  • PLSE 65.91

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About PLSE Pulse Biosciences Inc (DE)

Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed-Field Ablation or nsPFA technology when used to ablate cellular tissue, can be used to treat a variety of medical conditions for which an optimal solution remains unfulfilled. Substantial revenue is generated from North America Majorly due to the sale of systems.

Share on Social Networks: